secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROCEPT BioRobotics Corp (PRCT)
CIK:        0001588978
Form:       8-K
Filed at:   2023-07-27T23:59:59+00:00
Accession:  0001588978-23-000019
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PROCEPT BioRobotics Q2 revenue $33.1M (+98% YoY); raises FY2023 guidance to $131M
--------------------------------------------------------------------------------

- Record 40 U.S. AquaBeam systems sold in Q2; U.S. system revenue $14.8M (+74% YoY).
- U.S. handpiece & consumables revenue $13.6M (+138% YoY); utilization per account up 9%.
- Gross margin 56% (vs 51% prior year); narrowed net loss $25.3M vs $19.2M.
- FY2023 revenue guidance raised to $131M (from $128M); gross margin ~55% (from ~54%).
- United Healthcare issued positive coverage policy for Aquablation, effective June 1, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1588978/000158897823000019/0001588978-23-000019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1588978/000158897823000019/prct-20230727.htm
  HTML page:      https://secwatch.observer/filing/0001588978-23-000019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer